Shanghai unveiled a total of 186 major projects in its 2025 plan on Thursday, covering various sectors such as scientific and ...
The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...
Researchers have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. The research uncovers the vital role ...
Reckitt, a UK-based consumer goods company, announced the start of constructing its global research and development center in Shanghai with an investment of more than 300 million yuan ($40.92 million) ...
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
a spokesperson for the Insurance Information Institute (Triple-I). “However, the two most common types of life insurance—term and whole—may not be available to you after a cancer diagnosis.” ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Shanghai Junshi ...
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC ...
We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...
China Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University ...
Shanghai Fosun Pharmaceutical (Group ... This new chemical drug is intended as a treatment for advanced colorectal cancer in patients unsuitable for certain combination chemotherapies.